Genomic Valley Biotech Ltd Q1 FY2022-23 PAT climbs to Rs. 45.92 lakhs

has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 1.0482 crores during the period ended June 30, 2022 as compared to Rs. 0.0055 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 0.4592 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 0.1457 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 1.50 for the period ended June 30, 2022 as compared to Rs. 0.48 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 1.0482 crs	₹0.0055 crs	18,958.18%
Net Profit	₹0.4592 crs	₹0.1457 crs	215.17%
EPS	₹1.50	₹0.48	212.50%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 1.0482 crores during the period ended June 30, 2022 as compared to Rs.0.0169 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.0.4592 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.-0.1087 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.1.50 for the period ended June 30, 2022 as compared to Rs.-0.36 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 1.0482 crs	₹0.0169 crs	6,102.37%
Net Profit	₹0.4592 crs	₹-0.1087 crs	522.45%
EPS	₹1.50	₹-0.36	516.67%

Source : Equity Bulls

Keywords

GenomicValleyBiotech Q1FY23 ResultUpdate